These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 10340636)

  • 1. Reversibility of alendronate-induced contraction in human osteoclast-like cells formed from bone marrow cells in culture.
    Koshihara Y; Kodama S; Ishibashi H; Azuma Y; Ohta T; Karube S
    J Bone Miner Metab; 1999; 17(2):98-107. PubMed ID: 10340636
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of alendronate treatment on the osteoclastogenic potential of bone marrow cells in mice.
    van Beek ER; Löwik CW; Papapoulos SE
    Bone; 1997 Apr; 20(4):335-40. PubMed ID: 9108353
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Actin polymerization modulates CD44 surface expression, MMP-9 activation, and osteoclast function.
    Samanna V; Ma T; Mak TW; Rogers M; Chellaiah MA
    J Cell Physiol; 2007 Dec; 213(3):710-20. PubMed ID: 17508356
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Osteoblasts mediate insulin-like growth factor-I and -II stimulation of osteoclast formation and function.
    Hill PA; Reynolds JJ; Meikle MC
    Endocrinology; 1995 Jan; 136(1):124-31. PubMed ID: 7828521
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential effects of transforming growth factor-beta on osteoclast-like cell formation in mouse marrow culture: relation to the effect of zinc-chelating dipeptides.
    Yamaguchi M; Kishi S
    Peptides; 1995; 16(8):1483-8. PubMed ID: 8745062
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of alendronate on osteoclast differentiation and bone volume in transplanted bone.
    Kawata T; Tenjou K; Tokimasa C; Fujita T; Kaku M; Matsuki A; Kohno S; Tsutsui K; Ohtani J; Motokawa M; Shigekawa M; Tohma Y; Tanne K
    Exp Anim; 2004 Jan; 53(1):47-51. PubMed ID: 14993741
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 12-O-tetradecanoylphorbol-13-acetate inhibits osteoclast-like cell differentiation in rat bone marrow cultures by inducing macrophage polykaryons.
    Kukita T; Kukita A; Hata K; Kurisu K
    Endocrinology; 1992 Feb; 130(2):577-84. PubMed ID: 1310276
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of osteoclast apoptosis and motility by small GTPase binding protein Rac1.
    Fukuda A; Hikita A; Wakeyama H; Akiyama T; Oda H; Nakamura K; Tanaka S
    J Bone Miner Res; 2005 Dec; 20(12):2245-53. PubMed ID: 16294277
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differences in osteoclast formation between proximal and distal tibial osteoporosis in rats with adjuvant arthritis: inhibitory effects of bisphosphonates on osteoclasts.
    Shu G; Yamamoto K; Nagashima M
    Mod Rheumatol; 2006; 16(6):343-9. PubMed ID: 17164994
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bone resorption inhibitor alendronate normalizes the reduced bone thickness of TRPV5(-/-) mice.
    Nijenhuis T; van der Eerden BC; Hoenderop JG; Weinans H; van Leeuwen JP; Bindels RJ
    J Bone Miner Res; 2008 Nov; 23(11):1815-24. PubMed ID: 18597625
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regucalcin stimulates osteoclast-like cell formation in mouse marrow cultures.
    Yamaguchi M; Uchiyama S
    J Cell Biochem; 2005 Mar; 94(4):794-803. PubMed ID: 15578574
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Osteoclast activation: potent inhibition by the bisphosphonate alendronate through a nonresorptive mechanism.
    Owens JM; Fuller K; Chambers TJ
    J Cell Physiol; 1997 Jul; 172(1):79-86. PubMed ID: 9207928
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Osteoblasts/stromal cells stimulate osteoclast activation through expression of osteoclast differentiation factor/RANKL but not macrophage colony-stimulating factor: receptor activator of NF-kappa B ligand.
    Udagawa N; Takahashi N; Jimi E; Matsuzaki K; Tsurukai T; Itoh K; Nakagawa N; Yasuda H; Goto M; Tsuda E; Higashio K; Gillespie MT; Martin TJ; Suda T
    Bone; 1999 Nov; 25(5):517-23. PubMed ID: 10574571
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the alendronate and irradiation with a light-emitting diode (LED) on murine osteoclastogenesis.
    Sohn HM; Ko Y; Park M; Kim B; Park JE; Kim D; Moon YL; Lim W
    Lasers Med Sci; 2017 Jan; 32(1):189-200. PubMed ID: 27807651
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor necrosis factor-alpha cooperates with receptor activator of nuclear factor kappaB ligand in generation of osteoclasts in stromal cell-depleted rat bone marrow cell culture.
    Komine M; Kukita A; Kukita T; Ogata Y; Hotokebuchi T; Kohashi O
    Bone; 2001 May; 28(5):474-83. PubMed ID: 11344046
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cloning and identification of human Sca as a novel inhibitor of osteoclast formation and bone resorption.
    Choi SJ; Devlin RD; Menaa C; Chung H; Roodman GD; Reddy SV
    J Clin Invest; 1998 Oct; 102(7):1360-8. PubMed ID: 9769328
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of novel biphenyl carboxylic acid derivatives as novel antiresorptive agents that do not impair parathyroid hormone-induced bone formation.
    Idris AI; Greig IR; Bassonga-Landao E; Ralston SH; van 't Hof RJ
    Endocrinology; 2009 Jan; 150(1):5-13. PubMed ID: 18772231
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of bone resorption by alendronate and risedronate does not require osteoclast apoptosis.
    Halasy-Nagy JM; Rodan GA; Reszka AA
    Bone; 2001 Dec; 29(6):553-9. PubMed ID: 11728926
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preparation and characterization of a mouse osteoclast-like multinucleated cell population.
    Akatsu T; Tamura T; Takahashi N; Udagawa N; Tanaka S; Sasaki T; Yamaguchi A; Nagata N; Suda T
    J Bone Miner Res; 1992 Nov; 7(11):1297-306. PubMed ID: 1281605
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Breast cancer cells inhibit spontaneous and bisphosphonate-induced osteoclast apoptosis.
    Hussein O; Tiedemann K; Komarova SV
    Bone; 2011 Feb; 48(2):202-11. PubMed ID: 20849994
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.